PubMed Health⌕ Search

PubMed · 2397989

Eosinophilic pleural effusions.

Abstract

We present 2 cases of eosinophilic pleural effusion (EPE) seen recently at Straub Hospital. One occurred in a patient with pneumococcal empyema; the 2nd patient had 2 episodes of EPE secondary to malignant histiocytic lymphoma. Eosinophilic pleural effusion (EPE) is defined as having eosinophils exceeding 10% of the pleural fluid WBC differential. EPE is usually exudative, typically accounting for 1% to 8% of all pleural effusions. Up to 30% to 35% of EPE are idiopathic, while other frequent causes include air in the pleural space (30%), and pulmonary infections (10%). Collagen vascular diseases, tuberculosis and malignancies are common causes of EPE. Although spontaneous resolution and a favorable prognosis predominates in this entity, prudent clinical follow-up is advised. Since the first documented case of eosinophilic pleural effusion in 1984 by Harmsen, clinicians have attempted to determine its significance. This condition is defined as pleural effusion with greater than 10% of the WBC differential eosinophils. We saw 2 cases of EPE at Straub Hospital during 1988.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M S Lau, F D Pien. 1990. Eosinophilic pleural effusions.. https://pubmed.ncbi.nlm.nih.gov/2397989/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Nonallergic rhinitis with eosinophilia syndrome and related disorders.

NARES is a clinical syndrome consisting of symptoms consistent with AR in which an absence of atopy has been demonstrated by allergen skin testing, with nasal cytology analysis showing greater than 20% eosinophils. Anosmia is a prominent feature not shared with AR. The pathophysiology of NARES is poorly understood, but a key component involves a self-perpetuating, chronic eosinophilic nasal inflammation with development of nasal micropolyposis and polyposis. Mast cells likely play an important role as well. NARES is a risk factor for the development of nasal polyposis and aspirin sensitivity, as well as obstructive sleep apnea. Treatment consists mainly of intranasal corticosteroids with or without the addition of second-generation antihistamines and/or LT receptor antagonists as an adjuvant.

Eosinophilia↗